Medical device maker Optos believes it is closer to a sales breakthrough in the UK, now that an unnamed NHS trust has agreed to start testing the Optomap instrument.
Medical device maker Optos believes it is closer to a sales breakthrough in the UK, now that an unnamed NHS trust has agreed to start testing the Optomap instrument.
The eye scanning firm has sold few devices in the UK because of the complexities of the NHS purchasing system, according to a report in Scotland on Sunday (July 9), but chief executive Stephane Sallmard said that was likely to change now a PCT has agreed to trial Optomap.
Approval from one trust would make it far more likely that other NHS bodies would be willing to lease the device.
Register now to continue reading
Thank you for visiting Optician Online. Register now to access up to 10 news and opinion articles a month.
Register
Already have an account? Sign in here
